Skip to main content

Peer Review reports

From: Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study

Original Submission
23 May 2022 Submitted Original manuscript
18 Jul 2022 Reviewed Reviewer Report
2 Aug 2022 Reviewed Reviewer Report - Simone Parisi
16 Nov 2022 Author responded Author comments - Aaron Broadwell
Resubmission - Version 2
16 Nov 2022 Submitted Manuscript version 2
17 Nov 2022 Author responded Author comments - Aaron Broadwell
Resubmission - Version 3
17 Nov 2022 Submitted Manuscript version 3
18 Nov 2022 Author responded Author comments - Aaron Broadwell
Resubmission - Version 4
18 Nov 2022 Submitted Manuscript version 4
7 Feb 2023 Author responded Author comments - Aaron Broadwell
Resubmission - Version 5
7 Feb 2023 Submitted Manuscript version 5
16 Feb 2023 Author responded Author comments - Aaron Broadwell
Resubmission - Version 6
16 Feb 2023 Submitted Manuscript version 6
21 Feb 2023 Author responded Author comments - Aaron Broadwell
Resubmission - Version 7
21 Feb 2023 Submitted Manuscript version 7
Publishing
7 Mar 2023 Editorially accepted
27 Mar 2023 Article published 10.1186/s41927-023-00329-8

You can find further information about peer review here.

Back to article page